Evidence
for New Medical Products:
Implications for Patients and Health Policy
Date: June 13th, 2014
Time: 8:30
a.m. – 6:00 p.m.
Location: American Association for the Advancement of Science,
Washington, D.C.
Register here: http://www.aaas.org/oZT
This event is co-sponsored by the
American Association for the Advancement of Science, Division of
Pharmacoepidemiology and Pharmacoeconomics of Brigham and Women’s
Hospital/Harvard Medical School, and National Center for Health Research.
Conference Focus
Better implementation of
evidence-based medicine can improve the quality and cost-effectiveness of
health care in the U.S. This can be challenging in evaluating newly approved
drugs and medical devices.
While current law requires that medical products be proven safe and effective,
there is growing pressure to expedite access to promising therapies and to
lessen the research and regulatory requirements for manufacturers. Unmet
medical needs and patient demands call for a flexible approach to prescription
drug and device regulation, but
truncated premarket review may also lead to approval of products that are less
effective than expected or have unanticipated safety problems. This groundbreaking conference
will review the growing body of research on the medical and public health
implications of medical product approval criteria, and examine these findings
in the context of patient outcomes, costs, and health policy.
Confirmed Speakers Include (where are the harmed patient speakers?)
Jerry Avorn, MD, Professor,
Harvard Medical School; Greg Curfman, MD, Executive Editor, New England Journal
of Medicine; Congresswoman Rosa DeLauro; Aaron Kesselheim, MD, Harvard Medical
School; Bernard Lo, MD, President, Greenwall Foundation; Rita Redberg, MD,
Editor, JAMA Internal Medicine; Joseph Ross, MD, Yale Medical School; Patrick
Ryan, PhD, Janssen Research and Development; Sebastian Schneeweiss, MD, Harvard
Medical School; Lisa Schwartz, MD, Dartmouth; Joe Selby, MD, Executive
Director, Patient Centered Outcomes Research Institute; Steven Woloshin, MD,
Dartmouth; Robert Yarchoan, MD, National Cancer Institute; Diana
Zuckerman, PhD, National Center for Health Research.
For more details on the program
and registration, please go to http://www.aaas.org/oZT.
There is no cost for attending the event, but space is limited and advance
registration is required.
No comments:
Post a Comment